Skip to content

An open trial of mindfulness-based cognitive therapy for the prevention of perinatal depressive relapse/recurrence.

Sona Dimidjian, Sherryl H Goodman, Jennifer N. Felder, Robert Gallop, Amanda P Brown, Arne Beck

Archives of women's mental health February 2015 DOI: 10.1007/s00737-014-0468-x (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Single-arm feasibility study Randomized Peer reviewed
Sample size 49
Population Pregnant women with histories of depression recruited from obstetrics clinics at two sites of a large health maintenance organization
Duration Through 6-months postpartum
Topics Meditation
Key points MBCT-PD was associated with significant improvement in depressive symptom levels and an 18% rate of relapse/recurrence through 6 months postpartum among pregnant women with depression histories. The authors conclude the program shows promise as an acceptable, feasible, and clinically beneficial brief psychosocial prevention option, and that randomized controlled trials are needed to establish efficacy.

Abstract

Pregnant women with histories of depression are at high risk of depressive relapse/recurrence during the perinatal period, and options for relapse/recurrence prevention are limited. Mindfulness-based cognitive therapy (MBCT) has strong evidence among general populations but has not been studied among at-risk pregnant women to prevent depression. We examined the feasibility, acceptability, and clinical outcomes of depression symptom severity and relapse/recurrence associated with MBCT adapted for perinatal women (MBCT-PD). Pregnant women with depression histories were recruited from obstetrics clinics in a large health maintenance organization at two sites and enrolled in MBCT-PD (N = 49). Self-reported depressive symptoms and interview-based assessments of depression relapse/recurrence status were measured at baseline, during MBCT-PD, and through 6-months postpartum. Pregnant women reported interest, engagement, and satisfaction with the program. Retention rates were high, as were rates of completion of daily homework practices. Intent to treat analyses indicated a significant improvement in depression symptom levels and an 18 % rate of relapse/recurrence through 6 months postpartum. MBCT-PD shows promise as an acceptable, feasible, and clinically beneficial brief psychosocial prevention option for pregnant women with histories of depression. Randomized controlled trials are needed to examine the efficacy of MBCT-PD for the prevention of depressive relapse/recurrence during pregnancy and postpartum.

Comparable studies

Other non-randomized and open-label trials on meditation, most cited first.

Study Year Design Participants
Mindfulness-Based Stress Reduction in Relation to Quality of Life, Mood, Symptoms of Stress, and Immune Parameters in Breast and Prostate Cancer Outpatients Early-stage breast and prostate cancer patients 2003 Pre-post intervention study n = 59
Exploring self‐compassion and empathy in the context of mindfulness‐based stress reduction (MBSR) Community sample 2010 Pre-post intervention study
Mindfulness-Based Stress Reduction Lowers Psychological Distress In Medical Students Second-year medical students 2003 Prospective nonrandomized cohort-controlled study n = 302
Intensive meditation training, immune cell telomerase activity, and psychological mediators. Retreat participants and matched controls 2011 Controlled trial with wait-list control group n = 60
The Effectiveness of Mindfulness Training for Children with ADHD and Mindful Parenting for their Parents Children aged 8-12 with ADHD and their parents 2011 Within-group waitlist controlled trial n = 22

Citations in the library

Cited by 23

and 18 more in the library

Cites 17

and 12 more in the library

Explore topics